AI Article Synopsis
- The study assessed the use of a 755nm picosecond alexandrite laser for treating nevus of Ota in children, finding it to be safe and effective.
- A group of 305 pediatric patients achieved an average of 79% pigment clearance after about two treatments, with younger patients and those with darker lesions showing better results.
- Complications occurred in 12.1% of cases, mostly post-inflammatory hyperpigmentation, but the overall findings support early and frequent treatment for optimal outcomes.
Article Abstract
Background: The picosecond alexandrite laser has been safely and effectively used to treat the nevus of Ota in adults. However, limited data are available for children.
Objective: To investigate the efficacy, safety, and correlative influencing factors of a 755nm picosecond alexandrite laser in the treatment of nevus of Ota in children.
Methods: We retrospectively analyzed Chinese children with nevus of Ota who received a 755nm picosecond alexandrite laser treatment in a tertiary dermatological hospital.
Result: A total of 305 pediatric patients received an average of two treatments achieving an average of 79% pigment clearance. After the first treatment, 22 patients achieved complete clearance (95%-100%), and 72 patients achieved excellent response (75%-94%), with an average initial efficacy of 63% lesion clearance. Treatment at an early age achieved better initial efficacy (0- to 12-month group >1- to 6-year group, 6- to 12-year group). And 0- to 12-month group achieved better final efficacy. More treatment sessions also increased the final efficacy. Both initial efficacy and final efficacy were better when treating a darker lesion. The incidence of complications was 12.1%, with 10.8% being post-inflammatory hyperpigmentation and 1.3% being hypopigmentation. The rate of recurrence was 6.6%.
Limitation: Retrospective study.
Conclusion: A 755nm picosecond alexandrite laser is safe and effective in treating nevus of Ota in children. Younger to initiate treatment, darker lesions, and more treatments are positively associated with better pigmentation clearance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/lsm.23795 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fixed Drug Eruption-Induced Hyperpigmentation Treated With High-Fluence Picosecond Alexandrite Laser.
Dermatol Surg
December 2024
Setagaya Sonoda Dermatology Clinic, Setagaya, Setagaya-ku, Tokyo, Japan.
Background: Laser procedures are often used for global improvement in skin quality. The state of the skin is under stress after laser treatment, and it is beneficial to utilize topical agents to assist with optimal healing and cosmetic outcomes. Currently, such post-laser-cosmeceutical synergies are being investigated.
View Article and Find Full Text PDFPicosecond Alexandrite Laser With Diffractive Lens Array Combined With Long-Pulse Alexandrite Laser for the Treatment of Facial Photoaging in Chinese Women: A Retrospective Study.
Skin Res Technol
October 2024
Department of Cosmetology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Affiliated Zhejiang Chinese Medical University, Wenzhou, Zhejiang, China.
Article Synopsis
- Facial photoaging, mainly caused by UV radiation, leads to various skin issues like hyperpigmentation, wrinkles, and enlarged pores, prompting the need for effective treatments.
- This study examined the effects of treating 20 Chinese women with a combination of picosecond alexandrite laser (PSAL) and long-pulse alexandrite laser (LPAL) over three sessions, assessing both the skin's condition and patient satisfaction.
- Results showed significant improvements in multiple skin indices, high patient satisfaction (average score of 4.67), and no severe side effects, indicating that this combined laser treatment is both effective and safe for addressing facial photoaging.
Safety and efficacy of a picosecond 755-nm alexandrite laser combined with topical tranexamic acid in the treatment of melasma.
J Cosmet Dermatol
November 2024
Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Background: The picosecond 755-nm alexandrite laser and topical tranexamic acid (TA) have shown promise in treating melasma.
Aim: This aim of this study was to evaluate the efficacy and safety of combining to a picosecond 755-nm alexandrite laser combined with topical TA for melasma treatment.
Patients And Methods: Forty-eight patients' facial halves with bilateral symmetrical melasma were randomized to receive either topical TA and picosecond laser treatment or laser monotherapy.
Laser-induced optical breakdown is a prior strategy for acquired melanin-increased disorder in dermal layer.
Lasers Med Sci
August 2024
Mackay Memorial Hospital, Dermatology, No. 92, Sec. 2, Zhongshan N. Rd, Taipei, TW, Taiwan.
This brief report discusses the challenges in treating dermal melanosis and the limitations of current laser treatments due to inadequate tissue penetration and potential side effects. It introduces laser-induced optical breakdown (LIOB) as a novel therapeutic approach using a picosecond laser with a diffractive lens array (DLA) to target dermal pigmentation effectively. LIOB induces multiphoton ionization, leading to melanin clearance through phagocytosis and apoptotic cell removal, while also promoting dermal remodeling and collagen synthesis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!